Skip to content
  • Career
  • Support
  • Contact Us
Menu
  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Menu
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Search
Close
Menu
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get a Quote
    • Get Set Up
  • News & Events
    • News
    • Events
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us
  • All posts

AMRA Medical at EASD 2022 Conference: Two Abstracts Paving A New Path For Research With The Two Largest Diabetes Companies

AMRA Medical’s cutting-edge technology for body composition assessment was used in two separate studies for evaluating the effects of diabetes drugs—one being Lilly’s Tirzepatide, the other Novo Nordisk’s Liraglutide.
  • September 21, 2022

Linköping, Sweden, September 21, 2022: AMRA Medical — a health informatics company providing body composition measurements through magnetic resonance imaging (MRI) based software and analytical services — supports two abstracts accepted for presentation at The European Association for the Study of Diabetes (EASD) 2022 Annual Meeting. These presentations will cover the results of each study, which were performed to assess the effect of diabetes drugs using AMRA’s technology. The abstracts also highlight how researchers can use AMRA’s MRI-based platform and accompanying reference database to obtain individualized body composition measurements with precision and accuracy in people with diabetes.

The first abstract (#561) titled “Tirzepatide shows beneficial effects on body fat distribution pattern in people with type 2 diabetes” is the output of AMRA’s consultancy with pharmaceutical company Lilly. In this longitudinal study, researchers used body composition profiling (BCP) measurements, such as visceral adipose tissue and abdominal subcutaneous adipose tissue, as a readout to detect shifts in fat distribution patterns in response to drug administration over time. Notably, AMRA provided matched virtual control groups to each study participant with similar traits (e.g., sex and BMI). This allowed the researchers to relate actual changes in fat depots within the study participant to predicted changes, indicating whether any of the treatments had a targeted effect on one or several fat compartments.

The second abstract (#112) titled “Effect of liraglutide on muscle fat infiltration in adults with overweight or obesity: a randomized clinical trial” is the output of AMRA’s collaboration with medical centers, universities, and hospitals. In this study, researchers used AMRA’S BCP protocol to measure changes in muscle fat infiltration (MFI) in response to treatment with liraglutide and lifestyle interventions. Viewers of this presentation will learn if the reducing effect of liraglutide goes beyond total body weight and visceral fat to also impact muscle fat infiltration. Additionally, this clinical study goes further to investigate associations between changes in MFI and changes in cardiometabolic biomarkers, showing significant associations with biomarkers for heart failure and inflammation (e.g., NT-proBNP, CRP, etc.).

The EASD 2022 annual conference is being held from 19-24 September. Individuals can attend in person in Stockholm or online.

Conference attendees can connect with AMRA team members to learn how they can use AMRA’s technology in clinical trials and clinical practice to quantify specific fat depots upon treatment with diabetes drugs, detect shifts in fat distribution patterns over time, and how it can be applied to other interventions such as weight loss programs and nutrition plans.

About AMRA Medical

AMRA Medical is a health informatics company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision – all from a rapid whole-body MRI scan.

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • All posts
Research Services
Follow us
Linkedin Twitter Facebook

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support
  • Data Privacy Policy
  • Cookie Policy
  • Data Privacy Policy
  • Cookie Policy

Newsletter

    © 2023 AMRA Medical AB

    AMRA Medical
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}
    AMRA Medical
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}